Modeling and Simulation - QSP Archives

Case Study

How Model-informed drug development rescue projects from a risky situation

Discover how Certara’s integrated approach to model-informed drug development helps clients navigate regulatory challenges, achieve…

Certara2025年6月26日

Poster

Applications of an Immunogenicity QSP Platform: Predictive Modelling for ADA and PK Impact for Biotherapeutic Combinations

Learn how a QSP platform predicts ADA and PK effects in combo immunotherapies like nivolumab…

Certara2025年6月23日

Poster

QSP Modeling in Cancer Therapy | Advancing Tumor-Selective Treatments

Discover how Certara uses QSP modeling to advance the development of KK2269, a bispecific antibody…

Certara2025年6月18日

Poster

A minimal physiologically-based pharmacokinetic/pharmacodynamic mouse xenograft model to inform the evaluation of 212Pb-based Radio-DARPins targeting DLL3

Explore a cutting-edge minimal PBPK/PD oncology mouse model for 212Pb-based Radio-DARPin MP0712, meticulously designed to…

Certara2025年6月16日

Poster

A Quantitative Systems Pharmacology Model to Investigate the Crucial Role of Epithelial Damage in the Pathogenesis of Inflammatory Bowel Disease

In inflammatory bowel disease (IBD) patients, there is an imbalance between pro- and anti-inflammatory cytokines.…

Danielle Pillsbury2025年6月13日

Blog

Systems modeling helps optimize safety and efficacy for oncolytic viruses

2025年5月30日 Gene therapies delivered in viral vectors offer an exciting and challenging approach…

Certara2025年5月30日

On-Demand Webinar

Evolving Regulatory Landscape for Model Informed Drug Development (MIDD): Impact of the Draft ICH M15 Guidance

SVP, PBPK Consultancy Services, Certara SVP, Quantitative Science Services, Certara Sr. Director, Clinical Pharmacology, Certara…

Certara2025年5月23日

Blog

QSP Summit 2025: A New Standard in the Future of Drug Development

2025年5月5日 The Quantitative Systems Pharmacology (QSP) Summit 2025, hosted by Certara, marked another…

Certara2025年5月5日

Publication

A translational model-based meta-analysis to predict tremor incidence associated with serotonin reuptake transporter inhibition

The serotonin reuptake transporter (SERT) is responsible for the removal and recycling of the neurotransmitter…

Certara2025年4月30日

Poster

Clinical validation of a quantitative systems pharmacology (QSP) model of ISB 2001 used for deriving first in human (FIH) dose and efficient phase 1 dose escalation design in relapsed/refractory multiple myeloma (RRMM) patient

In partnership with Ichnos, Certara developed a QSP model to determine the most suitable therapeutic…

Certara2025年4月30日

Powered by Translations.com GlobalLink Web Software

Modeling and Simulation – QSP

How Model-informed drug development rescue projects from a risky situation

Applications of an Immunogenicity QSP Platform: Predictive Modelling for ADA and PK Impact for Biotherapeutic Combinations

QSP Modeling in Cancer Therapy | Advancing Tumor-Selective Treatments

A minimal physiologically-based pharmacokinetic/pharmacodynamic mouse xenograft model to inform the evaluation of 212Pb-based Radio-DARPins targeting DLL3

A Quantitative Systems Pharmacology Model to Investigate the Crucial Role of Epithelial Damage in the Pathogenesis of Inflammatory Bowel Disease

Systems modeling helps optimize safety and efficacy for oncolytic viruses

Evolving Regulatory Landscape for Model Informed Drug Development (MIDD): Impact of the Draft ICH M15 Guidance

QSP Summit 2025: A New Standard in the Future of Drug Development

A translational model-based meta-analysis to predict tremor incidence associated with serotonin reuptake transporter inhibition

Clinical validation of a quantitative systems pharmacology (QSP) model of ISB 2001 used for deriving first in human (FIH) dose and efficient phase 1 dose escalation design in relapsed/refractory multiple myeloma (RRMM) patient

メルマガ登録

クイックアクセス

ソリューション

お問合せ